Tag: #cancerresearch

The expected CAGR of global urothelial carcinoma treatment market is tend to be around 20% in the mentioned forecast period. The market was valued at USD 0.81 billion in 2022, and it would grow upto USD 3.48 billion by 2030

Data Bridge Market Research analyses that the radiation oncology treatment planning software market which was USD 2.18 billion in 2022, would rocket up to USD 4.34 billion by 2030, and is expected to undergo a CAGR of 9.00% during the forecast period 2023 to 2030

The global non-small cell lung cancer diagnostics market is expected to reach USD 3,463.37 million by 2028 from USD 1,291.66 million in 2020, growing at a steady CAGR of 13.2% in the forecast period of 2021 to 2028.